These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38908555)

  • 1. Validation of screening instruments for common mental disorders and suicide risk in south African primary care settings.
    Stockton MA; Mazinyo EW; Mlanjeni L; Sweetland AC; Scharf JY; Nogemane K; Ngcelwane N; Basaraba C; Bezuidenhout C; Sansbury G; Olivier D; Grobler C; Wall MM; Medina-Marino A; Nobatyi P; Wainberg ML
    J Affect Disord; 2024 Oct; 362():161-168. PubMed ID: 38908555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Mental Health Screening Tools After Mild Traumatic Brain Injury.
    Gitaari M; Mikolic A; Panenka WJ; Silverberg ND
    JAMA Netw Open; 2024 Jul; 7(7):e2424076. PubMed ID: 39042406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women.
    van Heyningen T; Honikman S; Tomlinson M; Field S; Myer L
    PLoS One; 2018; 13(4):e0193697. PubMed ID: 29668725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe.
    Chibanda D; Verhey R; Gibson LJ; Munetsi E; Machando D; Rusakaniko S; Munjoma R; Araya R; Weiss HA; Abas M
    J Affect Disord; 2016 Jul; 198():50-5. PubMed ID: 27011359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Validation of PHQ-9 and GAD-7 in Filipino Migrant Domestic Workers in Macao (SAR), China.
    Garabiles MR; Lao CK; Yip P; Chan EWW; Mordeno I; Hall BJ
    J Pers Assess; 2020; 102(6):833-844. PubMed ID: 31361153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Depression and Anxiety Among Adolescents in South Africa: Validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7.
    Marlow M; Skeen S; Grieve CM; Carvajal-Velez L; Åhs JW; Kohrt BA; Requejo J; Stewart J; Henry J; Goldstone D; Kara T; Tomlinson M
    J Adolesc Health; 2023 Jan; 72(1S):S52-S60. PubMed ID: 36274021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
    Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
    J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries.
    Mughal AY; Devadas J; Ardman E; Levis B; Go VF; Gaynes BN
    BMC Psychiatry; 2020 Jun; 20(1):338. PubMed ID: 32605551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa.
    Baron EC; Davies T; Lund C
    BMC Psychiatry; 2017 Jan; 17(1):6. PubMed ID: 28068955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of common mental disorders in a community health centre sample.
    Ahmad F; Shakya Y; Ginsburg L; Lou W; Ng PT; Rashid M; Ferrari M; Ledwos C; McKenzie K
    Can Fam Physician; 2016 Dec; 62(12):e758-e766. PubMed ID: 27965352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a brief mental health screening tool for common mental disorders in primary healthcare.
    Bhana A; Mntambo N; Gigaba SG; Luvuno ZPB; Grant M; Ackerman D; Ntswe E; Nomathemba M; Petersen I
    S Afr Med J; 2019 Mar; 109(4):278-283. PubMed ID: 31084695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of brief screening instruments for internalizing and externalizing disorders in Mozambican adolescents.
    Lovero KL; Adam SE; Bila CE; Canda ED; Fernandes ME; Rodrigues TIB; Sander MCT; Mellins CA; Duarte CS; Dos Santos PF; Wainberg ML
    BMC Psychiatry; 2022 Aug; 22(1):549. PubMed ID: 35962378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
    Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR
    Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation.
    Levitt EE; Syan SK; Sousa S; Costello MJ; Rush B; Samokhvalov AV; McCabe RE; Kelly J; MacKillop J
    Addict Behav; 2021 Jan; 112():106649. PubMed ID: 32979691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Patient Health Questionnaire-4 (PHQ-4) to screen for depression and anxiety in the Greek general population.
    Christodoulaki A; Baralou V; Konstantakopoulos G; Touloumi G
    J Psychosom Res; 2022 Sep; 160():110970. PubMed ID: 35728338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.
    Sawaya H; Atoui M; Hamadeh A; Zeinoun P; Nahas Z
    Psychiatry Res; 2016 May; 239():245-52. PubMed ID: 27031595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.
    Hitchon CA; Zhang L; Peschken CA; Lix LM; Graff LA; Fisk JD; Patten SB; Bolton J; Sareen J; El-Gabalawy R; Marriott J; Bernstein CN; Marrie RA
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1130-1139. PubMed ID: 31199570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
    Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
    Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
    Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
    J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care.
    Cano-Vindel A; Muñoz-Navarro R; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Gómez-Castillo MD; Capafons A; Chacón F; Santolaya F;
    J Affect Disord; 2018 Jul; 234():247-255. PubMed ID: 29549826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.